Two Sigma Investments’s Juno Therapeutics, Inc. JUNO Stock Holding History

Two Sigma Investments’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,000	Closed	-$449K	–	3623
2017 Q3	$449K	Buy	+10,000	New	+$341K	﹤0.01%	2204
2016 Q4	–	Sell	-15,500	Closed	-$465K	–	3701
2016 Q3	$465K	Sell	15,500 -13,800	-47%	-$429K	﹤0.01%	2485
2016 Q2	$1.13M	Buy	+29,300	New	+$1.22M	﹤0.01%	1652
2015 Q4	–	Sell	-12,000	Closed	-$488K	–	3140
2015 Q3	$488K	Buy	+12,000	New	+$526K	﹤0.01%	1552

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Two Sigma Investments's JUNO Position: Q1 2018 in Review

Two Sigma Investments sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 149,969 shares — an estimated $6.86M sold.

Two Sigma Investments first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $11.5M in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Two Sigma Investments reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Two Sigma Investments sold 149,969 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $6.86M.
Two Sigma Investments first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
Two Sigma Investments's Juno Therapeutics, Inc. position peaked at $11.5M in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Two Sigma Investments's 13F filing for Q1 2018, filed 15 May 2018.